VIEIRA ROBERTO WANDENKOLK enters CORCEPT THERAPEUTICS INC with 4.07K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/4/2026ACC: 0001193125-26-382432
Officer· President, Oncology
Since Sep 2026
4.07K
Baseline shares
100% direct
4.07K
Direct ownership
1 position
480K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned4.07K
Total
4.07K direct4.07K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 4.07K | Direct |
| Total | 4.07K | 4.07K direct |
Derivative Holdings3
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
140K
Shares owned
N/A
Exercise price
60.58
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
140K
Shares owned
N/A
Exercise price
35.70
Expiration
—
Exercise window
—
Stock option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
200K
Shares owned
N/A
Exercise price
21.63
Expiration
—
Exercise window
—
Total
Underlying
480K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock | 60.58 | — | — | 140K | N/A |
| Stock option (right to buy) Direct | Common Stock | 35.70 | — | — | 140K | N/A |
| Stock option (right to buy) Direct | Common Stock | 21.63 | — | — | 200K | N/A |
| Total | 480K | 0.00 | ||||